Are these summer drug price increases hot enough to steal the spotlight from rebates?
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, Tecfidera, Humira, PBM, FTC, GLP-1, Gardasil, Tepezza, Enbrel, Abrilada, lofena, meloxicam, Diclofenac, propranolol, dexmethylphenidate, lisdexamfetamine, Methylphenidate, mercaptopurine, Quetiapine, Guanfacine, Dextroamphetamine, Paliperidone, trazodone
New drug pricing report showcases highs, lows, distorted incentives, and brokenness of Medicare Part D
